Bile acid supplement shows promise for gut inflammation in early trial
NCT ID NCT04114292
First seen Mar 11, 2026 · Last updated May 12, 2026 · Updated 9 times
Summary
This early-phase study tested whether TUDCA, a natural bile acid, is safe and can reduce stress in gut cells of people with active ulcerative colitis. Fourteen adults took TUDCA for 6 weeks while researchers monitored side effects and measured changes in cell stress markers from colon biopsies. The goal was to see if TUDCA could help control disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
-
Barnes-Jewish West County Hospital
Creve Coeur, Missouri, 63141, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.